- The effects of COVID-19 on physician’s burnout: a systematic review
-
Kang MJ, Park JH
- KMID: 2520195
- J Korean Med Assoc.
- 2021 Sep;64(9):636-646.
- doi: 10.5124/jkma.2021.64.9.636
Background: To suggest measures to prevent burnout of physicians during the coronavirus disease 2019 (COVID-19) pandemic, we conducted a systematic review of research on physician burnout due to COVID-19. Methods: Three... -
- CITED
-
- Close
- SHARE
-
- Close
- Intestinal microbiota and inflammatory bowel diseases
-
Eun CS
- KMID: 2520189
- J Korean Med Assoc.
- 2021 Sep;64(9):588-595.
- doi: 10.5124/jkma.2021.64.9.588
Background: The prevalence of inflammatory bowel diseases (IBD) has been rapidly increasing over the past several decades in Korea. IBD appears to be resulted from inappropriate and chronic activation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Anesthesiologist’s role as a communication coordinator of perioperative medicine: stressing the recognition of role in the changing medical atmosphere
-
Yon JH, Kang BJ
- KMID: 2520194
- J Korean Med Assoc.
- 2021 Sep;64(9):631-635.
- doi: 10.5124/jkma.2021.64.9.631
Background: Perioperative care process in a hospital is considerably complex, involving multiple subprocesses, healthcare professionals, and systems in support of surgical care. The perioperative process is often the primary source... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of inflammatory bowel diseases in Korea
-
Yang SK
- KMID: 2520187
- J Korean Med Assoc.
- 2021 Sep;64(9):572-577.
- doi: 10.5124/jkma.2021.64.9.572
Background: Inflammatory bowel disease (IBD) is a disease of unknown origin that causes chronic inflammation of the intestines and is classified as either ulcerative colitis or Crohn’s disease. The incidence... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of inflammatory bowel diseases: focusing on biologic agents and new therapies
-
Song HY, Seo GS
- KMID: 2520191
- J Korean Med Assoc.
- 2021 Sep;64(9):605-613.
- doi: 10.5124/jkma.2021.64.9.605
Background: The treatment of inflammatory bowel diseases has evolved with the development of anti-tumor necrosis factor agents. Despite the long-term effectiveness, many patients experience primary non-response, secondary loss of response,... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutics for acute otitis media
-
Kown J, Chung J
- KMID: 2520193
- J Korean Med Assoc.
- 2021 Sep;64(9):624-630.
- doi: 10.5124/jkma.2021.64.9.624
Background: Acute otitis media (AOM) is diagnosed in patients with acute onset of signs and symptoms of inflammation in the middle ear, accompanied by middle ear effusion. AOM is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiology and diagnosis of inflammatory bowel diseases
-
Lee KM
- KMID: 2520188
- J Korean Med Assoc.
- 2021 Sep;64(9):579-587.
- doi: 10.5124/jkma.2021.64.9.579
Background: Over the past three decades, inflammatory bowel diseases (IBD) have been rapidly increasing in the African, South American, and Asian countries, including Korea. However, in Korea, the public awareness... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of inflammatory bowel diseases: focusing on 5-aminosalicylates and immunomodulators
-
Kim YS
- KMID: 2520190
- J Korean Med Assoc.
- 2021 Sep;64(9):596-604.
- doi: 10.5124/jkma.2021.64.9.596
Background: Recently, the incidence and prevalence rates of inflammatory bowel disease (IBD) have increased worldwide, including in Korea. Although there has been considerable progress in the management of IBD following... -
- CITED
-
- Close
- SHARE
-
- Close
- Classification, diagnosis, and treatment of vascular malformations
-
Lee JS, Chung HY
- KMID: 2520192
- J Korean Med Assoc.
- 2021 Sep;64(9):614-621.
- doi: 10.5124/jkma.2021.64.9.614
Background: In the 1980s, vascular anomalies were divided into two major subgroups—vascular tumors and vascular malformations—based on the functional framework. This concept has been fundamental to the management of vascular... -
- CITED
-
- Close
- SHARE
-
- Close
